img

Global Weight-loss Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Weight-loss Drugs Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Weight-loss Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Weight-loss Drugs market research.
Key manufacturers engaged in the Weight-loss Drugs industry include Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd, Swiss Research Labs Ltd., Roar Ambition, Health and Nutrition Ltd., Abbott and Kellogg Company, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Weight-loss Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Weight-loss Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Weight-loss Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novo Nordisk
Currax
Ultimate life ltd
Wolfson Berg Ltd
Swiss Research Labs Ltd.
Roar Ambition
Health and Nutrition Ltd.
Abbott
Kellogg Company
Glanbia PLC
Ajinomoto Co. Inc.
Kraft Heinz Company
GlaxoSmithKline PLC
Herbalife Nutrition Ltd.
PepsiCo
Nestle
Amway Corp.
Segment by Type
Liquid
Powder
Softgels
Pills
Others

Segment by Application


Online Sales
Hospitals and Clinics
Pharmacy
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Weight-loss Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Weight-loss Drugs Market Overview
1.1 Product Overview and Scope of Weight-loss Drugs
1.2 Weight-loss Drugs Segment by Type
1.2.1 Global Weight-loss Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Liquid
1.2.3 Powder
1.2.4 Softgels
1.2.5 Pills
1.2.6 Others
1.3 Weight-loss Drugs Segment by Application
1.3.1 Global Weight-loss Drugs Market Value by Application: (2024-2034)
1.3.2 Online Sales
1.3.3 Hospitals and Clinics
1.3.4 Pharmacy
1.3.5 Others
1.4 Global Weight-loss Drugs Market Size Estimates and Forecasts
1.4.1 Global Weight-loss Drugs Revenue 2024-2034
1.4.2 Global Weight-loss Drugs Sales 2024-2034
1.4.3 Global Weight-loss Drugs Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Weight-loss Drugs Market Competition by Manufacturers
2.1 Global Weight-loss Drugs Sales Market Share by Manufacturers (2024-2024)
2.2 Global Weight-loss Drugs Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Weight-loss Drugs Average Price by Manufacturers (2024-2024)
2.4 Global Weight-loss Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Weight-loss Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Weight-loss Drugs, Product Type & Application
2.7 Weight-loss Drugs Market Competitive Situation and Trends
2.7.1 Weight-loss Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Weight-loss Drugs Players Market Share by Revenue
2.7.3 Global Weight-loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Weight-loss Drugs Retrospective Market Scenario by Region
3.1 Global Weight-loss Drugs Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Weight-loss Drugs Global Weight-loss Drugs Sales by Region: 2024-2034
3.2.1 Global Weight-loss Drugs Sales by Region: 2024-2024
3.2.2 Global Weight-loss Drugs Sales by Region: 2024-2034
3.3 Global Weight-loss Drugs Global Weight-loss Drugs Revenue by Region: 2024-2034
3.3.1 Global Weight-loss Drugs Revenue by Region: 2024-2024
3.3.2 Global Weight-loss Drugs Revenue by Region: 2024-2034
3.4 North America Weight-loss Drugs Market Facts & Figures by Country
3.4.1 North America Weight-loss Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Weight-loss Drugs Sales by Country (2024-2034)
3.4.3 North America Weight-loss Drugs Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Weight-loss Drugs Market Facts & Figures by Country
3.5.1 Europe Weight-loss Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Weight-loss Drugs Sales by Country (2024-2034)
3.5.3 Europe Weight-loss Drugs Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Weight-loss Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Weight-loss Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Weight-loss Drugs Sales by Country (2024-2034)
3.6.3 Asia Pacific Weight-loss Drugs Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Weight-loss Drugs Market Facts & Figures by Country
3.7.1 Latin America Weight-loss Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Weight-loss Drugs Sales by Country (2024-2034)
3.7.3 Latin America Weight-loss Drugs Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Weight-loss Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Weight-loss Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Weight-loss Drugs Sales by Country (2024-2034)
3.8.3 Middle East and Africa Weight-loss Drugs Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Weight-loss Drugs Sales by Type (2024-2034)
4.1.1 Global Weight-loss Drugs Sales by Type (2024-2024)
4.1.2 Global Weight-loss Drugs Sales by Type (2024-2034)
4.1.3 Global Weight-loss Drugs Sales Market Share by Type (2024-2034)
4.2 Global Weight-loss Drugs Revenue by Type (2024-2034)
4.2.1 Global Weight-loss Drugs Revenue by Type (2024-2024)
4.2.2 Global Weight-loss Drugs Revenue by Type (2024-2034)
4.2.3 Global Weight-loss Drugs Revenue Market Share by Type (2024-2034)
4.3 Global Weight-loss Drugs Price by Type (2024-2034)
5 Segment by Application
5.1 Global Weight-loss Drugs Sales by Application (2024-2034)
5.1.1 Global Weight-loss Drugs Sales by Application (2024-2024)
5.1.2 Global Weight-loss Drugs Sales by Application (2024-2034)
5.1.3 Global Weight-loss Drugs Sales Market Share by Application (2024-2034)
5.2 Global Weight-loss Drugs Revenue by Application (2024-2034)
5.2.1 Global Weight-loss Drugs Revenue by Application (2024-2024)
5.2.2 Global Weight-loss Drugs Revenue by Application (2024-2034)
5.2.3 Global Weight-loss Drugs Revenue Market Share by Application (2024-2034)
5.3 Global Weight-loss Drugs Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Novo Nordisk Weight-loss Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Currax
6.2.1 Currax Corporation Information
6.2.2 Currax Description and Business Overview
6.2.3 Currax Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Currax Weight-loss Drugs Product Portfolio
6.2.5 Currax Recent Developments/Updates
6.3 Ultimate life ltd
6.3.1 Ultimate life ltd Corporation Information
6.3.2 Ultimate life ltd Description and Business Overview
6.3.3 Ultimate life ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Ultimate life ltd Weight-loss Drugs Product Portfolio
6.3.5 Ultimate life ltd Recent Developments/Updates
6.4 Wolfson Berg Ltd
6.4.1 Wolfson Berg Ltd Corporation Information
6.4.2 Wolfson Berg Ltd Description and Business Overview
6.4.3 Wolfson Berg Ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Wolfson Berg Ltd Weight-loss Drugs Product Portfolio
6.4.5 Wolfson Berg Ltd Recent Developments/Updates
6.5 Swiss Research Labs Ltd.
6.5.1 Swiss Research Labs Ltd. Corporation Information
6.5.2 Swiss Research Labs Ltd. Description and Business Overview
6.5.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio
6.5.5 Swiss Research Labs Ltd. Recent Developments/Updates
6.6 Roar Ambition
6.6.1 Roar Ambition Corporation Information
6.6.2 Roar Ambition Description and Business Overview
6.6.3 Roar Ambition Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Roar Ambition Weight-loss Drugs Product Portfolio
6.6.5 Roar Ambition Recent Developments/Updates
6.7 Health and Nutrition Ltd.
6.6.1 Health and Nutrition Ltd. Corporation Information
6.6.2 Health and Nutrition Ltd. Description and Business Overview
6.6.3 Health and Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio
6.7.5 Health and Nutrition Ltd. Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Abbott Weight-loss Drugs Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Kellogg Company
6.9.1 Kellogg Company Corporation Information
6.9.2 Kellogg Company Description and Business Overview
6.9.3 Kellogg Company Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Kellogg Company Weight-loss Drugs Product Portfolio
6.9.5 Kellogg Company Recent Developments/Updates
6.10 Glanbia PLC
6.10.1 Glanbia PLC Corporation Information
6.10.2 Glanbia PLC Description and Business Overview
6.10.3 Glanbia PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Glanbia PLC Weight-loss Drugs Product Portfolio
6.10.5 Glanbia PLC Recent Developments/Updates
6.11 Ajinomoto Co. Inc.
6.11.1 Ajinomoto Co. Inc. Corporation Information
6.11.2 Ajinomoto Co. Inc. Weight-loss Drugs Description and Business Overview
6.11.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio
6.11.5 Ajinomoto Co. Inc. Recent Developments/Updates
6.12 Kraft Heinz Company
6.12.1 Kraft Heinz Company Corporation Information
6.12.2 Kraft Heinz Company Weight-loss Drugs Description and Business Overview
6.12.3 Kraft Heinz Company Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Kraft Heinz Company Weight-loss Drugs Product Portfolio
6.12.5 Kraft Heinz Company Recent Developments/Updates
6.13 GlaxoSmithKline PLC
6.13.1 GlaxoSmithKline PLC Corporation Information
6.13.2 GlaxoSmithKline PLC Weight-loss Drugs Description and Business Overview
6.13.3 GlaxoSmithKline PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.13.4 GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio
6.13.5 GlaxoSmithKline PLC Recent Developments/Updates
6.14 Herbalife Nutrition Ltd.
6.14.1 Herbalife Nutrition Ltd. Corporation Information
6.14.2 Herbalife Nutrition Ltd. Weight-loss Drugs Description and Business Overview
6.14.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio
6.14.5 Herbalife Nutrition Ltd. Recent Developments/Updates
6.15 PepsiCo
6.15.1 PepsiCo Corporation Information
6.15.2 PepsiCo Weight-loss Drugs Description and Business Overview
6.15.3 PepsiCo Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.15.4 PepsiCo Weight-loss Drugs Product Portfolio
6.15.5 PepsiCo Recent Developments/Updates
6.16 Nestle
6.16.1 Nestle Corporation Information
6.16.2 Nestle Weight-loss Drugs Description and Business Overview
6.16.3 Nestle Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Nestle Weight-loss Drugs Product Portfolio
6.16.5 Nestle Recent Developments/Updates
6.17 Amway Corp.
6.17.1 Amway Corp. Corporation Information
6.17.2 Amway Corp. Weight-loss Drugs Description and Business Overview
6.17.3 Amway Corp. Weight-loss Drugs Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Amway Corp. Weight-loss Drugs Product Portfolio
6.17.5 Amway Corp. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Weight-loss Drugs Industry Chain Analysis
7.2 Weight-loss Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Weight-loss Drugs Production Mode & Process
7.4 Weight-loss Drugs Sales and Marketing
7.4.1 Weight-loss Drugs Sales Channels
7.4.2 Weight-loss Drugs Distributors
7.5 Weight-loss Drugs Customers
8 Weight-loss Drugs Market Dynamics
8.1 Weight-loss Drugs Industry Trends
8.2 Weight-loss Drugs Market Drivers
8.3 Weight-loss Drugs Market Challenges
8.4 Weight-loss Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Weight-loss Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Weight-loss Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Weight-loss Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Weight-loss Drugs Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Weight-loss Drugs Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Weight-loss Drugs Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Weight-loss Drugs Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Weight-loss Drugs Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Weight-loss Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Weight-loss Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Weight-loss Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Weight-loss Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Weight-loss Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight-loss Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Weight-loss Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Weight-loss Drugs Sales by Region (2024-2024) & (K Units)
Table 18. Global Weight-loss Drugs Sales Market Share by Region (2024-2024)
Table 19. Global Weight-loss Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Weight-loss Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Weight-loss Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Weight-loss Drugs Revenue Market Share by Region (2024-2024)
Table 23. Global Weight-loss Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Weight-loss Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Weight-loss Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Weight-loss Drugs Sales by Country (2024-2024) & (K Units)
Table 27. North America Weight-loss Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Weight-loss Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Weight-loss Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Weight-loss Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Weight-loss Drugs Sales by Country (2024-2024) & (K Units)
Table 32. Europe Weight-loss Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Weight-loss Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Weight-loss Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Weight-loss Drugs Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Weight-loss Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Weight-loss Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Weight-loss Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Weight-loss Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Weight-loss Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Weight-loss Drugs Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Weight-loss Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Weight-loss Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Weight-loss Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Weight-loss Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Weight-loss Drugs Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Weight-loss Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Weight-loss Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Weight-loss Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Weight-loss Drugs Sales (K Units) by Type (2024-2024)
Table 51. Global Weight-loss Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Weight-loss Drugs Sales Market Share by Type (2024-2024)
Table 53. Global Weight-loss Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Weight-loss Drugs Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Weight-loss Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Weight-loss Drugs Revenue Market Share by Type (2024-2024)
Table 57. Global Weight-loss Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Weight-loss Drugs Price (US$/Unit) by Type (2024-2024)
Table 59. Global Weight-loss Drugs Price (US$/Unit) by Type (2024-2034)
Table 60. Global Weight-loss Drugs Sales (K Units) by Application (2024-2024)
Table 61. Global Weight-loss Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Weight-loss Drugs Sales Market Share by Application (2024-2024)
Table 63. Global Weight-loss Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Weight-loss Drugs Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Weight-loss Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Weight-loss Drugs Revenue Market Share by Application (2024-2024)
Table 67. Global Weight-loss Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Weight-loss Drugs Price (US$/Unit) by Application (2024-2024)
Table 69. Global Weight-loss Drugs Price (US$/Unit) by Application (2024-2034)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Novo Nordisk Weight-loss Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Currax Corporation Information
Table 76. Currax Description and Business Overview
Table 77. Currax Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Currax Weight-loss Drugs Product
Table 79. Currax Recent Developments/Updates
Table 80. Ultimate life ltd Corporation Information
Table 81. Ultimate life ltd Description and Business Overview
Table 82. Ultimate life ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Ultimate life ltd Weight-loss Drugs Product
Table 84. Ultimate life ltd Recent Developments/Updates
Table 85. Wolfson Berg Ltd Corporation Information
Table 86. Wolfson Berg Ltd Description and Business Overview
Table 87. Wolfson Berg Ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Wolfson Berg Ltd Weight-loss Drugs Product
Table 89. Wolfson Berg Ltd Recent Developments/Updates
Table 90. Swiss Research Labs Ltd. Corporation Information
Table 91. Swiss Research Labs Ltd. Description and Business Overview
Table 92. Swiss Research Labs Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Swiss Research Labs Ltd. Weight-loss Drugs Product
Table 94. Swiss Research Labs Ltd. Recent Developments/Updates
Table 95. Roar Ambition Corporation Information
Table 96. Roar Ambition Description and Business Overview
Table 97. Roar Ambition Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Roar Ambition Weight-loss Drugs Product
Table 99. Roar Ambition Recent Developments/Updates
Table 100. Health and Nutrition Ltd. Corporation Information
Table 101. Health and Nutrition Ltd. Description and Business Overview
Table 102. Health and Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Health and Nutrition Ltd. Weight-loss Drugs Product
Table 104. Health and Nutrition Ltd. Recent Developments/Updates
Table 105. Abbott Corporation Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Abbott Weight-loss Drugs Product
Table 109. Abbott Recent Developments/Updates
Table 110. Kellogg Company Corporation Information
Table 111. Kellogg Company Description and Business Overview
Table 112. Kellogg Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Kellogg Company Weight-loss Drugs Product
Table 114. Kellogg Company Recent Developments/Updates
Table 115. Glanbia PLC Corporation Information
Table 116. Glanbia PLC Description and Business Overview
Table 117. Glanbia PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Glanbia PLC Weight-loss Drugs Product
Table 119. Glanbia PLC Recent Developments/Updates
Table 120. Ajinomoto Co. Inc. Corporation Information
Table 121. Ajinomoto Co. Inc. Description and Business Overview
Table 122. Ajinomoto Co. Inc. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Ajinomoto Co. Inc. Weight-loss Drugs Product
Table 124. Ajinomoto Co. Inc. Recent Developments/Updates
Table 125. Kraft Heinz Company Corporation Information
Table 126. Kraft Heinz Company Description and Business Overview
Table 127. Kraft Heinz Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Kraft Heinz Company Weight-loss Drugs Product
Table 129. Kraft Heinz Company Recent Developments/Updates
Table 130. GlaxoSmithKline PLC Corporation Information
Table 131. GlaxoSmithKline PLC Description and Business Overview
Table 132. GlaxoSmithKline PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. GlaxoSmithKline PLC Weight-loss Drugs Product
Table 134. GlaxoSmithKline PLC Recent Developments/Updates
Table 135. Herbalife Nutrition Ltd. Corporation Information
Table 136. Herbalife Nutrition Ltd. Description and Business Overview
Table 137. Herbalife Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Herbalife Nutrition Ltd. Weight-loss Drugs Product
Table 139. Herbalife Nutrition Ltd. Recent Developments/Updates
Table 140. PepsiCo Corporation Information
Table 141. PepsiCo Description and Business Overview
Table 142. PepsiCo Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. PepsiCo Weight-loss Drugs Product
Table 144. PepsiCo Recent Developments/Updates
Table 145. Nestle Corporation Information
Table 146. Nestle Description and Business Overview
Table 147. Nestle Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Nestle Weight-loss Drugs Product
Table 149. Nestle Recent Developments/Updates
Table 150. Amway Corp. Corporation Information
Table 151. Amway Corp. Description and Business Overview
Table 152. Amway Corp. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Amway Corp. Weight-loss Drugs Product
Table 154. Amway Corp. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Weight-loss Drugs Distributors List
Table 158. Weight-loss Drugs Customers List
Table 159. Weight-loss Drugs Market Trends
Table 160. Weight-loss Drugs Market Drivers
Table 161. Weight-loss Drugs Market Challenges
Table 162. Weight-loss Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Weight-loss Drugs
Figure 2. Global Weight-loss Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Weight-loss Drugs Market Share by Type in 2022 & 2034
Figure 4. Liquid Product Picture
Figure 5. Powder Product Picture
Figure 6. Softgels Product Picture
Figure 7. Pills Product Picture
Figure 8. Others Product Picture
Figure 9. Global Weight-loss Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Weight-loss Drugs Market Share by Application in 2022 & 2034
Figure 11. Online Sales
Figure 12. Hospitals and Clinics
Figure 13. Pharmacy
Figure 14. Others
Figure 15. Global Weight-loss Drugs Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Weight-loss Drugs Market Size (2024-2034) & (US$ Million)
Figure 17. Global Weight-loss Drugs Sales (2024-2034) & (K Units)
Figure 18. Global Weight-loss Drugs Average Price (US$/Unit) & (2024-2034)
Figure 19. Weight-loss Drugs Report Years Considered
Figure 20. Weight-loss Drugs Sales Share by Manufacturers in 2022
Figure 21. Global Weight-loss Drugs Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Weight-loss Drugs Players: Market Share by Revenue in 2022
Figure 23. Weight-loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 24. Global Weight-loss Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 25. North America Weight-loss Drugs Sales Market Share by Country (2024-2034)
Figure 26. North America Weight-loss Drugs Revenue Market Share by Country (2024-2034)
Figure 27. United States Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Canada Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Europe Weight-loss Drugs Sales Market Share by Country (2024-2034)
Figure 30. Europe Weight-loss Drugs Revenue Market Share by Country (2024-2034)
Figure 31. Germany Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. France Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. U.K. Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Italy Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Russia Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Asia Pacific Weight-loss Drugs Sales Market Share by Region (2024-2034)
Figure 37. Asia Pacific Weight-loss Drugs Revenue Market Share by Region (2024-2034)
Figure 38. China Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Japan Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. South Korea Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. India Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Australia Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. China Taiwan Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Latin America Weight-loss Drugs Sales Market Share by Country (2024-2034)
Figure 46. Latin America Weight-loss Drugs Revenue Market Share by Country (2024-2034)
Figure 47. Mexico Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Brazil Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Argentina Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Weight-loss Drugs Sales Market Share by Country (2024-2034)
Figure 51. Middle East & Africa Weight-loss Drugs Revenue Market Share by Country (2024-2034)
Figure 52. Turkey Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. UAE Weight-loss Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Weight-loss Drugs by Type (2024-2034)
Figure 56. Global Revenue Market Share of Weight-loss Drugs by Type (2024-2034)
Figure 57. Global Weight-loss Drugs Price (US$/Unit) by Type (2024-2034)
Figure 58. Global Sales Market Share of Weight-loss Drugs by Application (2024-2034)
Figure 59. Global Revenue Market Share of Weight-loss Drugs by Application (2024-2034)
Figure 60. Global Weight-loss Drugs Price (US$/Unit) by Application (2024-2034)
Figure 61. Weight-loss Drugs Value Chain
Figure 62. Weight-loss Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed